{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:20:29Z","timestamp":1761513629137},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.parkreldis.2015.04.026","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T06:39:52Z","timestamp":1430635192000},"page":"823-824","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Speech myoclonus due to probable pregabalin adverse drug-reaction"],"prefix":"10.1016","volume":"21","author":[{"given":"Diana A.","family":"Olszewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albi J.","family":"Chalissery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2015.04.026_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1756285610395653","article-title":"Myoclonic disorders: a practical approach for diagnosis and treatment","volume":"4","author":"Kojovic","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.parkreldis.2015.04.026_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2042098613505614","article-title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","volume":"5","author":"Toth","year":"2014","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.parkreldis.2015.04.026_bib3","unstructured":"US Food and Drug Administration, www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/021446s013s014lbl.pdf."},{"key":"10.1016\/j.parkreldis.2015.04.026_bib4","series-title":"Dialysis of drugs","author":"Bailie","year":"2013"},{"key":"10.1016\/j.parkreldis.2015.04.026_bib5","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.22286","article-title":"Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure","volume":"24","author":"Healy","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.04.026_bib6","first-page":"138","article-title":"Two cases of pregabalin neurotoxicity in chronic kidney disease patients","volume":"4","author":"Lee","year":"2011","journal-title":"NDT Plus"},{"key":"10.1016\/j.parkreldis.2015.04.026_bib7","unstructured":"Essential Medicines and Health Products Information Portal, A World Health Organization resource http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js4882e\/7.7.html."},{"key":"10.1016\/j.parkreldis.2015.04.026_bib8","unstructured":"The use of the WHO-UMC system for standardised case causality assessment, http:\/\/who-umc.org\/Graphics\/24734.pdf."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015001911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015001911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T23:20:55Z","timestamp":1537658455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802015001911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1353802015001911"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.04.026","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Speech myoclonus due to probable pregabalin adverse drug-reaction","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}